Alterity Therapeutics ATHE
NASDAQ ATHE
$2.39 -0.04 (-1.65%)
At close: Oct 21, 2026 · 4:00 PM EDT

Alterity Therapeutics (ATHE) EBITDA (2016 - 2018)

Updated

Alterity Therapeutics (ATHE) recorded EBITDA of -$7.72 trillion in the year ended Jun 30, 2025, compared with -$12.55 trillion a year earlier.

Analysis

Alterity Therapeutics (ATHE) EBITDA (2016 - 2018) Analysis & Trends

Starting with the year ended Jun 30, 2009, Alterity Therapeutics' EBITDA history includes 12 years.

  • The figure for the year ended Jun 30, 2025 is the highest annual EBITDA since the year ended Jun 30, 2018.
  • Per Business Quant data, ATHE's EBITDA was -$12.55 trillion in the year ended Jun 30, 2024, -$9.13 trillion in the year ended Jun 30, 2023, -$9.14 trillion in the year ended Jun 30, 2022 and -$11.79 trillion in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 12.29 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 9.10 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 8.33 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 999.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 5.09 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.63 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -9.70 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 5.89 Bn
10 Alterity Therapeutics 41.90 Mn -41.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -3.84 Mn
Dec 31, 2017 -2.79 Mn
Dec 31, 2016 -2.75 Mn
API Access

Alterity Therapeutics EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ATHE&period=max&api_key=YOUR_API_KEY